Engrail Therapeutics

Engrail Therapeutics’ US$32 Million Extension Of Its Series A Financing

By Martina Bellini

Hogan Lovells Engrail Therapeutics on the deal. Engrail Therapeutics recently completed US$32 million extension of its Series A financing round, bringing the total to US$64 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

2ONE Labs Inc. et al v. ITG Brands, LLC

Construction Partners’ Acquisition of Overland Corporation

Eton Pharmaceuticals’ Acquisition of Galzin®

Grupo Mateus’ Business Combination With Novo Atacarejo

Central Bank of the Republic of Argentina’s $1 Billion Repurchase Agreement

Opea Agro Insumos’ R$608 Million Public Offering

Macquarie’s €320m Acquisition of Therme Erding

United Internet’s €800m Financing for 5G Expansion

Erste Group’s Share Buyback

Tasaheel for Financing’s Securitization Transaction

B.Tech’s Securitization

Al Ahly Tamkeen’s Securitization

Rawasi Al Bina’s SAR500 Million Sukuk Issuance Programme

Tamkeen Human Resource Company’s $105.8 Million IPO On Tadawul

Savola Group’s Rights Offering and Acquisition of Stake in Almarai Company

Harley Davidson Motor Company’s Collaboration Agreement with Hero MotoCorp Limited

Mt K Kapital’s Investment Round

Lupin Limited’s Acquisition of Huminsulin

FGvW Appoints Four New Local Partners as of January 2025

Reed Smith Promotes 24 to Partner and 31 to Counsel Globally

Real Estate Attorney Janet Lindeman Rejoins Quarles Chicago Office as Partner

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

FGvW Appoints Four New Local Partners as of January 2025

Reed Smith Promotes 24 to Partner and 31 to Counsel Globally

Real Estate Attorney Janet Lindeman Rejoins Quarles Chicago Office as Partner

Engrail Therapeutics’ US$32 Million Extension Of Its Series A Financing

Standard 1 Year Membership Required